GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 5-6, 2010, Pages 463-474

  Ku, Hui Chun ^a   Chen, Wen Pin ^a   Su, Ming Jai ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cardiac function; Dipeptidyl peptidase 4; Endotoxemia; Glucagon like peptide 1; Pressure volume loops

Indexed keywords

CYCLIC AMP; DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; LIPOPOLYSACCHARIDE; PHENYLEPHRINE; PHOSPHOLAMBAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEART CONTRACTION; HEART DISEASE; HEART FUNCTION; HEMODYNAMICS; MULTIPLE TRAUMA; NONHUMAN; ORGAN INJURY; PROTEIN PHOSPHORYLATION; RAT; SEPTIC SHOCK; SURVIVAL RATE; UPREGULATION; VASOCONSTRICTION;

ANIMALS; AORTA; CALCIUM-BINDING PROTEINS; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENDOTOXEMIA; GLUCAGON-LIKE PEPTIDE 1; LIPOPOLYSACCHARIDES; MULTIPLE ORGAN FAILURE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOCARDIUM; PEPTIDES; PHOSPHORYLATION; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; SIGNAL TRANSDUCTION; VENOMS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 78649930490     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0559-9     Document Type: Article

References (53)

1. M Arakawa T Mita K Azuma C Ebato H Goto T Nomiyama Y Fujitani T Hirose R Kawamori H Watada 2010 Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4 Diabetes 59 1030 1037 1:CAS:528:DC%2BC3cXltFSmtL0%3D 20068138 10.2337/db09-1694
2. K Ban MH Noyan-Ashraf J Hoefer SS Bolz DJ Drucker M Husain 2008 Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways Circulation 117 2340 2350 1:CAS:528:DC%2BD1cXltFyltrY%3D 18427132 10.1161/CIRCULATIONAHA.107.739938 (Pubitemid 351653542)
3. K Ban KH Kim CK Cho M Sauve EP Diamandis PH Backx DJ Drucker M Husain 2010 Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor Endocrinology 151 1520 1531 1:CAS:528:DC%2BC3cXks1CmtrY%3D 20172966 10.1210/en.2009-1197
4. N Bendet E Scapa O Cohen O Bloch D Aharoni Y Ramot M Weiss A Halevi MJ Rapoport 2004 Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in Crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection Scand J Gastroenterol 39 650 656 1:CAS:528:DC%2BD2cXmslCgtb0%3D 15370686 10.1080/00365520410004839 (Pubitemid 38916241)
5. J Blanco A Muriel-Bombin V Sagredo F Taboada F Gandia L Tamayo J Collado A Garcia-Labattut D Carriedo M Valledor M De Frutos MJ Lopez A Caballero J Guerra B Alvarez A Mayo J Villar 2008 Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study Crit Care 12 R158 19091069
6. E Boonacker CJ Van Noorden 2003 The multifunctional or moonlighting protein CD26/DPPIV Eur J Cell Biol 82 53 73 1:CAS:528:DC%2BD3sXjt12hsLY%3D 12647932 10.1078/0171-9335-00302 (Pubitemid 36285042)
7. C Chisholm GR Greenberg 2002 Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures Am J Physiol Endocrinol Metab 283 E311 E317 1:CAS:528:DC%2BD38XmslSgsL0%3D 12110536
8. D De Backer J Creteur E Silva JL Vincent 2003 Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31 1659 1667 12794401 10.1097/01.CCM.0000063045. 77339.B6 (Pubitemid 36714218)
9. J Doupis A Veves 2008 DPP4 inhibitors: a new approach in diabetes treatment Adv Ther 25 627 643 1:CAS:528:DC%2BD1cXhsVyqtL7K 18641927 10.1007/s12325-008-0076-1
10. DJ Drucker 2006 The biology of incretin hormones Cell Metab 3 153 165 1:CAS:528:DC%2BD28Xislyhtr4%3D 16517403 10.1016/j.cmet.2006.01.004
11. JM East 2000 Sarco(endo)plasmic reticulum calcium pumps: recent advances in our understanding of structure/function and biology (review) Mol Membr Biol 17 189 200 1:CAS:528:DC%2BD3MXis1yiu7k%3D 11302372 10.1080/09687680010009646 (Pubitemid 32267316)
12. MJ Faber M Dalinghaus IM Lankhuizen P Steendijk WC Hop RG Schoemaker DJ Duncker JM Lamers WA Helbing 2006 Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops Am J Physiol Heart Circ Physiol 291 H1580 H1586 1:CAS:528:DC%2BD28XhtFegtrbP 16679397 10.1152/ajpheart.00286.2006 (Pubitemid 44497661)
13. MR Farmer RE Roberts SM Gardiner V Ralevic 2003 Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta J Pharmacol Exp Ther 306 538 545 1:CAS:528:DC%2BD3sXlslGltb0%3D 12730359 10.1124/jpet.103.051805 (Pubitemid 36886152)
14. HC Fehmann R Goke B Goke 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide Endocr Rev 16 390 410 1:CAS:528:DyaK2MXmslCqtbY%3D 7671853
15. M Felies S von Horsten R Pabst H Nave 2004 Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats J Physiol 561 245 252 1:CAS:528:DC%2BD2cXhtVehu77I 15388781 10.1113/jphysiol.2004.073635 (Pubitemid 39549480)
16. S Frantz G Ertl J Bauersachs 2007 Mechanisms of disease: Toll-like receptors in cardiovascular disease Nat Clin Pract Cardiovasc Med 4 444 454 1:CAS:528:DC%2BD2sXotVOiu78%3D 17653117 10.1038/ncpcardio0938 (Pubitemid 47180328)
17. DJ Grieve RS Cassidy BD Green 2009 Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? Br J Pharmacol 157 1340 1351 1:CAS:528:DC%2BD1MXhsVKmu7%2FE 19681866 10.1111/j.1476-5381.2009.00376.x
18. L Hansen B Hartmann T Bisgaard H Mineo PN Jorgensen JJ Holst 2000 Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum Am J Physiol Endocrinol Metab 278 E1010 E1018 1:CAS:528:DC%2BD3cXks1Knt74%3D 10827002
19. L Hansen B Hartmann H Mineo JJ Holst 2004 Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum Regul Pept 118 11 18 1:CAS:528:DC%2BD2cXpsVOrsw%3D%3D 14759551 10.1016/j.regpep.2003.10.021 (Pubitemid 38167361)
20. GJ Hauser AK Myers EK Dayao Z Zukowska-Grojec 1993 Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock Am J Physiol 265 H1416 H1423 1:CAS:528:DyaK2cXks1Gksg%3D%3D 7902007
21. MR Hayes BC De Jonghe SE Kanoski 2010 Role of the glucagon-like-peptide-1 receptor in the control of energy balance Physiol Behav 100 503 510 1:CAS:528:DC%2BC3cXntlWqtrs%3D 20226203 10.1016/j.physbeh.2010.02.029
22. T Iwai S Ito K Tanimitsu S Udagawa J Oka 2006 Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes Neurosci Res 55 352 360 1:CAS:528:DC%2BD28XlsFKktrw%3D 16720054 10.1016/j.neures.2006.04.008 (Pubitemid 43866249)
23. SB Jones FD Romano 1990 Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock Circ Shock 30 51 61 1:CAS:528:DyaK3cXhsFGqu7c%3D 2154342
24. A Kumar V Thota L Dee J Olson E Uretz JE Parrillo 1996 Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum J Exp Med 183 949 958 1:CAS:528:DyaK28XhvV2qsr0%3D 8642298 10.1084/jem.183.3.949 (Pubitemid 26113964)
25. LE Kuo K Abe Z Zukowska 2007 Stress, NPY and vascular remodeling: implications for stress-related diseases Peptides 28 435 440 1:CAS:528:DC%2BD2sXhtlansLw%3D 17241699 10.1016/j.peptides.2006.08.035 (Pubitemid 46176248)
26. AM Lambeir S Scharpe I De Meester 2008 DPP4 inhibitors for diabetes-what next? Biochem Pharmacol 76 1637 1643 1:CAS:528:DC%2BD1cXhsVGgtr%2FK 18755155 10.1016/j.bcp.2008.07.029
27. M Leone C Martin 2008 Vasopressor use in septic shock: an update Curr Opin Anaesthesiol 21 141 147 18443479 10.1097/ACO.0b013e3282f46d20
28. RJ Levy 2007 Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis Shock 28 24 28 1:CAS:528: DC%2BD2sXotV2gt7k%3D 17483747 10.1097/01.shk.0000235089.30550.2d (Pubitemid 46956458)
29. D Marguet L Baggio T Kobayashi AM Bernard M Pierres PF Nielsen U Ribel T Watanabe DJ Drucker N Wagtmann 2000 Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 Proc Natl Acad Sci USA 97 6874 6879 1:CAS:528:DC%2BD3cXktFahsb0%3D 10823914 10.1073/pnas.120069197 (Pubitemid 30412807)
30. PE Marik M Raghavan 2004 Stress-hyperglycemia, insulin and immunomodulation in sepsis Intensive Care Med 30 748 756 14991101 10.1007/s00134-004-2167-y (Pubitemid 38639464)
31. MC Martinez B Muller JC Stoclet R Andriantsitohaina 1996 Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery Br J Pharmacol 118 1218 1222 1:CAS:528:DyaK28Xks1Ghsbg%3D 8818346
32. A Matsuyama-Yokono A Tahara R Nakano Y Someya M Hayakawa M Shibasaki 2009 Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin- nicotinamide-induced diabetic mice Naunyn-Schmiedeberg's Arch Pharmacol 379 191 199 1:CAS:528:DC%2BD1MXpvVGqtw%3D%3D 10.1007/s00210-008-0348-x
33. AM McKillop NA Duffy JR Lindsay FP O'Harte PM Bell PR Flatt 2008 Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects Diabetes Res Clin Pract 79 79 85 1:CAS:528:DC%2BD1cXisFOisw%3D%3D 17904681 10.1016/j.diabres.2007. 08.001
34. MC Michel E Fliers CJ Van Noorden 2008 Dipeptidyl peptidase IV inhibitors in diabetes: more than inhibition of glucagon-like peptide-1 metabolism? Naunyn Schmiedebergs Arch Pharmacol 377 205 207 1:CAS:528:DC%2BD1cXkvVSitbY%3D 18398599 10.1007/s00210-008-0280-0
35. AL Moens HC Champion MJ Claeys B Tavazzi PM Kaminski MS Wolin DJ Borgonjon L Van Nassauw A Haile M Zviman D Bedja FL Wuyts RS Elsaesser P Cos KL Gabrielson G Lazzarino N Paolocci JP Timmermans CJ Vrints DA Kass 2008 High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury Circulation 117 1810 1819 1:CAS:528:DC%2BD1cXktV2lt7Y%3D 18362233 10.1161/CIRCULATIONAHA.107.725481 (Pubitemid 351507469)
36. C Morimoto SF Schlossman 1998 The structure and function of CD26 in the T-cell immune response Immunol Rev 161 55 70 1:CAS:528:DyaK1cXitlyms7o%3D 9553764 10.1111/j.1600-065X.1998.tb01571.x (Pubitemid 28119018)
37. HB Nguyen EP Rivers FM Abrahamian GJ Moran E Abraham S Trzeciak DT Huang T Osborn D Stevens DA Talan 2006 Severe sepsis and septic shock: review of the literature and emergency department management guidelines Ann Emerg Med 48 28 54 16781920
38. LA Nikolaidis D Elahi T Hentosz A Doverspike R Huerbin L Zourelias C Stolarski YT Shen RP Shannon 2004 Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy Circulation 110 955 961 1:CAS:528:DC%2BD2cXms1OgtLw%3D 15313949 10.1161/01.CIR.0000139339.85840.DD (Pubitemid 39128621)
39. LA Nikolaidis D Elahi YT Shen RP Shannon 2005 Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy Am J Physiol Heart Circ Physiol 289 H2401 H2408 1:CAS:528:DC%2BD28XlslGnug%3D%3D 16024574 10.1152/ajpheart.00347. 2005 (Pubitemid 41698549)
40. MH Noyan-Ashraf MA Momen K Ban AM Sadi YQ Zhou AM Riazi LL Baggio RM Henkelman M Husain DJ Drucker 2009 GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice Diabetes 58 975 983 1:CAS:528:DC%2BD1MXktleiu7o%3D 19151200 10.2337/db08-1193
41. A Ossum U van Deurs T Engstrom JS Jensen M Treiman 2009 The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart Pharmacol Res 60 411 417 1:CAS:528:DC%2BD1MXhtFSnsrvM 19540343 10.1016/j.phrs.2009.06.004
42. JR Parratt 1998 Nitric oxide in sepsis and endotoxaemia J Antimicrob Chemother 41 Suppl A 31 39 1:CAS:528:DyaK1cXhtlWjt7o%3D 9511084 10.1093/jac/41.suppl-1.31(Pubitemid 28062142)
43. SD Prabhu 2004 Cytokine-induced modulation of cardiac function Circ Res 95 1140 1153 1:CAS:528:DC%2BD2cXhtVensrjL 15591236 10.1161/01.RES.0000150734. 79804.92 (Pubitemid 39648205)
44. HB Qiu Y Yang SX Zhou SH Liu RQ Zheng 2001 Prognostic value of dobutamine stress test in patients with septic shock Acta Pharmacol Sin 22 71 75 1:CAS:528:DC%2BD3MXht1Kksr0%3D 11730566
45. PA Read FZ Khan PM Heck SP Hoole DP Dutka 2010 DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease Circ Cardiovasc Imaging 3 195 201 20075143 10.1161/CIRCIMAGING.109.899377
46. NC Riedemann RF Guo PA Ward 2003 Novel strategies for the treatment of sepsis Nat Med 9 517 524 1:CAS:528:DC%2BD3sXjtlamt7Y%3D 12724763 10.1038/nm0503-517 (Pubitemid 36597096)
47. JA Russell 2006 Management of sepsis N Engl J Med 355 1699 1713 1:CAS:528:DC%2BD28XhtFWgu7vF 17050894 10.1056/NEJMra043632 (Pubitemid 44583960)
48. GG Sokos LA Nikolaidis S Mankad D Elahi RP Shannon 2006 Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure J Card Fail 12 694 699 1:CAS:528:DC%2BD28XhtlaqsrzK 17174230 10.1016/j.cardfail.2006.08.211 (Pubitemid 44881367)
49. Y Someya A Tahara R Nakano A Matsuyama-Yokono I Nagase Y Fukunaga T Takasu M Hayakawa M Shibasaki 2008 Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo Naunyn Schmiedebergs Arch Pharmacol 377 209 217 1:CAS:528: DC%2BD1cXkvVSitbw%3D 18398600 10.1007/s00210-008-0277-8
50. MA Thompson K Ohnuma M Abe C Morimoto NH Dang 2007 CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders Mini Rev Med Chem 7 253 273 1:CAS:528:DC%2BD2sXitVOitL4%3D 17346218 10.2174/138955707780059853 (Pubitemid 46488249)
51. SL Zanotti-Cavazzoni SM Hollenberg 2009 Cardiac dysfunction in severe sepsis and septic shock Curr Opin Crit Care 15 392 397 19633546 10.1097/MCC.0b013e3283307a4e
52. MM Zaruba HD Theiss M Vallaster U Mehl S Brunner R David R Fischer L Krieg E Hirsch B Huber P Nathan L Israel A Imhof N Herbach G Assmann R Wanke J Mueller-Hoecker G Steinbeck WM Franz 2009 Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4 313 323 1:CAS:528:DC%2BD1MXltVeqsro%3D 19341621 10.1016/j.stem.2009.02. 013
53. 2+ handling and shortening in sepsis Crit Care Med 33 598 604 15753753 10.1097/01.CCM.0000152223.27176.A6 (Pubitemid 40365563)